Avgol
Executive Summary
Avgol is a producer of nonwoven materials for hygiene, medical, and healthcare products, including baby diapers, female hygiene products, wipes, and masks. The company has been developing spunmelt nonwoven materials for more than 20 years, and it is known for its high-quality light and soft materials. As of 2025, the company’s revenue is estimated at USD 374.9 million. The company faces a net loss because of high interest expenses and increasing operating costs.
Company Overview
Avgol manufactures nonwoven fabrics. They use advanced technology like spun-melt to create fabrics. It is used in the hygiene and medical fields.
It was founded by Achai Bonneh and Shuki Goldwasser in 1988. It is based in Israel. The company has been owned by Indorama Ventures since 2018.
Industry Overview
The industry produces non-woven fabrics which are used to produce various products such as baby diapers, sanitary pads, medical masks, wipes, surgical gowns, and other industrial uses. Compared to normal fabrics, the non-woven fabrics are produced through sophisticated technologies like spunmelt, making them lightweight, durable, soft, and affordable.
The growth of the industry results from high levels of hygiene awareness and health care demands, among others.
Year | Revenue $ Million |
2023 | 318.067 |
2024 | 350.027 |
2025 | 374.941 |
4. Financial Performance Analysis
Particulars (USD Million) | 2023 | 2024 | 2025 |
Revenue / Net Sales | 318.067 | 350.027 | 374.941 |
Gross Profit | 45.363 | 48.374 | 46.964 |
Operating EBITDA | 42.352 | 44.711 | 44.12 |
Net Profit | 3.993 | -0.62 | -2.077 |
4.1. Key Financials YoY
4.2 Revenue Trend Over 3–5 Years
4.3 Interpretation
- Revenues in 2025 increased due to greater sales and higher demand for hygiene and medical products.
- Gross Profit in 2025 declined due to increased costs of production and operations.
- EBITDA is constant because of consistent operational performance and cost management.
- The company made a net profit in 2023, but then a net loss occurred due to higher interest costs and higher expenses.
Key Financial Ratios
Ratio | Formula | 2025 Value | Brief Interpretation |
Current Ratio | Current Assets / Current Liabilities | 0.85 | Current assets of the firm are less than current liabilities, indicating a low liquidity position. |
Gross Margin % | Gross Profit / Revenue × 100 | 12.53% | The company earned about 12.5% gross profit from its sales revenue. |
Net Margin % | Net Profit / Revenue × 100 | -0.55% | The net margin ratio indicated that there was some net loss for the company even though the revenues increased. |
Return on Equity (ROE) | Net Profit / Shareholders’ Equity × 100 | -1.02% | It indicates that there was a loss incurred by the company for its shareholders in the year 2025. |
Debt-to-Equity Ratio | Total Debt / Shareholders’ Equity | 0.87 | The company uses a moderate level of debt financing compared to equity. |
Interest Coverage Ratio | EBIT / Interest Expense | 1.08 Times | Operating earnings were only slightly higher than interest expense, indicating limited interest coverage ability. |
Asset Turnover | Revenue / Total Assets | 0.81 Times | The company generated USD 0.81 revenue for every USD 1 invested in assets. |
Swot Analysis
Strengths | Weaknesses |
Strong global presence in the hygiene and nonwoven fabric industry | Net losses reported in 2024 and 2025 |
Advanced spunmelt and nonwoven fabric technology | High dependence on polypropylene raw material prices |
Long-term relationships with global hygiene product manufacturers | High interest expenses affecting profitability |
Focus on innovation, soft fabrics, and sustainable products | Weak short-term liquidity position |
Opportunities | Threats |
Growing global demand for hygiene and medical products | Intense competition in the nonwoven fabric industry |
Expansion in emerging markets like Asia and Africa | Fluctuations in raw material and oil prices |
Rising demand for sustainable and recyclable materials | Global economic slowdown and geopolitical risks |
Development of lightweight and high-quality fabrics | Oversupply in China reducing industry margins |
Peer / Competitor Comparison
Company | Revenue (USD Billion) | Margin % | Debt/Equity |
Avgol Industries | 0.37 | -0.55% | 0.87 |
Freudenberg | 12.68 | 9.30% | 0.75 |
Ahlstrom | 3.17 | 16.10% | 6.46 |
Conclusion and Recommendations
Avgol revenue increased in 2025 because of growing demand for hygiene and medical products. But because of high interest and operating costs, profit decreased, and caused a net loss. The company has strong technology and stable operational performance. Based on the company’s growth potential and financial condition, the recommendation is Hold / Expand with Caution.
References and Sources
- Avgol Industries 2025 Annual Report
- Avgol Official Website
- Yahoo Finance – Avgol Financial Data